Title
Phytosterols: From Preclinical Evidence to Potential Clinical Applications
Date Issued
14 January 2021
Access level
open access
Resource Type
review
Author(s)
Salehi B.
Sharifi-Rad J.
Cruz-Martins N.
Nigam M.
Mishra A.P.
Konovalov D.A.
Orobinskaya V.
Abu-Reidah I.M.
Zam W.
Sharopov F.
Venneri T.
Capasso R.
Kukula-Koch W.
Wawruszak A.
Koch W.
Universidad Arturo Prat
Publisher(s)
Frontiers Media S.A.
Abstract
Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.
Volume
11
Language
English
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular Química medicinal
Scopus EID
2-s2.0-85100146683
Source
Frontiers in Pharmacology
ISSN of the container
16639812
Sponsor(s)
NCM acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/ 28076/2017).
Sources of information: Directorio de Producción Científica Scopus